Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?

Expression of galectin-3 in fine-needle

Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms

✍ Hidenori Inohara; Yuichiro Honjo; Tadashi Yoshii; Shiro Akahani; Jun-ichi Yoshid 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 724 KB

## BACKGROUND. Galectin-3 is a ␤-galactoside-binding protein that has been reported to be expressed preferentially in thyroid malignancies. The current study was designed to substantiate this finding further and to establish a presurgical diagnostic modality of differentiating between benign and ma